TScan Therapeutics (TCRX) Short Interest Ratio & Short Volume → Exposed: 10 CENT Crypto to Explode May 20th? (From True Market Insiders) (Ad) Free TCRX Stock Alerts $9.19 +0.21 (+2.34%) (As of 05/20/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media TScan Therapeutics Short Interest DataCurrent Short Interest398,000 sharesPrevious Short Interest419,700 sharesChange Vs. Previous Month-5.17%Dollar Volume Sold Short$3.07 millionShort Interest Ratio1.9 Days to CoverLast Record DateApril 30, 2024Outstanding Shares52,860,000 sharesFloat Size38,530,000 sharesShort Percent of Float1.03%Today's Trading Volume250,721 sharesAverage Trading Volume174,783 sharesToday's Volume Vs. Average143% Short Selling TScan Therapeutics ? Sign up to receive the latest short interest report for TScan Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTCRX Short Interest Over TimeTCRX Days to Cover Over TimeTCRX Percentage of Float Shorted Over Time Ad True Market InsidersExposed: 10 CENT Crypto to Explode May 20th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…Click For My #1 FREE Crypto for 2024 TScan Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024398,000 shares $3.07 million -5.2%1.0%1.9 $7.72 4/15/2024419,700 shares $3.23 million +91.3%1.1%2.2 $7.69 3/31/2024219,400 shares $1.74 million +16.5%0.6%1.3 $7.94 3/15/2024188,300 shares $1.34 million +0.3%0.5%1.2 $7.12 2/29/2024187,700 shares $1.27 million -25.8%0.5%1.2 $6.75 2/15/2024252,900 shares $1.45 million +3.8%0.7%1.6 $5.74 Get the Latest News and Ratings for TCRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TScan Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024243,600 shares $1.24 million -6.4%0.6%1.8 $5.11 1/15/2024260,300 shares $1.56 million -14.6%0.7%2 $6.00 12/31/2023304,700 shares $1.78 million -14.1%0.8%2.3 $5.83 12/15/2023354,700 shares $1.76 million -5.0%0.9%3.1 $4.95 11/30/2023373,300 shares $2.44 million -10.3%1.0%3.1 $6.53 11/15/2023416,000 shares $1.98 million -11.6%1.1%3.5 $4.76 10/31/2023470,700 shares $1.81 million -10.5%1.2%4.4 $3.85 10/15/2023526,000 shares $1.77 million -7.2%1.4%5.1 $3.37 9/30/2023566,900 shares $1.45 million +50.5%1.5%4.7 $2.56 9/15/2023376,800 shares $1.09 million +12.5%1.0%2.9 $2.89 8/31/2023334,800 shares $796,824.00 -5.0%0.9%2.5 $2.38 8/15/2023352,300 shares $739,830.00 -9.8%0.9%1.4 $2.10 7/31/2023390,700 shares $875,168.00 +9.0%0.9%0.3 $2.24 7/15/2023358,400 shares $756,224.00 -5.6%0.8%0.2 $2.11 6/30/2023379,600 shares $949,000.00 -5.6%0.9%0.3 $2.50 6/15/2023401,900 shares $1.09 million -19.6%1.0%0.3 $2.72 5/31/2023499,900 shares $1.15 million +19.8%1.4%0.4 $2.30 5/15/2023417,400 shares $1.68 million +365.9%2.9%0.3 $4.03 4/30/202389,600 shares $203,392.00 -2.3%0.7%0.1 $2.27 4/15/202391,700 shares $200,823.00 -24.7%0.7%0.6 $2.19 3/31/2023121,700 shares $255,570.00 -21.0%0.9%0.8 $2.10 3/15/2023154,000 shares $403,480.00 -2.0%1.2%1 $2.62 2/28/2023157,100 shares $463,445.00 +4.0%1.2%1 $2.95 2/15/2023151,000 shares $407,700.00 -50.3%1.2%1 $2.70 1/31/2023303,800 shares $552,916.00 +109.7%3.3%2.2 $1.82 1/15/2023144,900 shares $318,780.00 -1.6%1.6%1.1 $2.20 12/30/2022147,200 shares $228,160.00 +1.1%1.6%5.8 $1.55 12/15/2022145,600 shares $276,640.00 -5.9%1.6%7.4 $1.90 11/30/2022154,800 shares $334,368.00 -3.9%1.7%8.5 $2.16 11/15/2022161,000 shares $431,480.00 +14.9%1.8%8.5 $2.68 10/31/2022140,100 shares $378,270.00 +151.5%1.5%7.3 $2.70 10/15/202255,700 shares $167,100.00 -7.0%0.6%2.6 $3.00 9/30/202259,900 shares $182,695.00 +12.6%0.7%3 $3.05 9/15/202253,200 shares $173,432.00 +731.3%0.6%2.5 $3.26Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. 8/31/20226,400 shares $17,600.00 -96.8%0.1%0.3 $2.75 8/15/2022202,300 shares $681,751.00 +12.3%2.2%9.9 $3.37 7/31/2022180,200 shares $791,078.00 +8.8%2.0%1.9 $4.39 7/15/2022165,700 shares $565,037.00 +5.5%1.8%1.7 $3.41 6/30/2022157,000 shares $493,765.00 -0.2%1.7%1.5 $3.15 6/15/2022157,300 shares $493,922.00 +17.0%1.7%1.3 $3.14 5/31/2022134,500 shares $430,400.00 -41.9%1.5%1.1 $3.20 5/15/2022231,600 shares $576,684.00 +830.1%2.5%1.9 $2.49 4/30/202224,900 shares $53,535.00 +11.2%0.3%0.4 $2.15 4/15/202222,400 shares $58,912.00 +1.8%0.3%0.5 $2.63 3/31/202222,000 shares $61,600.00 +31.0%0.3%0.5 $2.80 3/15/202216,800 shares $60,648.00 -35.6%0.2%0.5 $3.61 2/28/202226,100 shares $109,620.00 -20.7%0.3%0.7 $4.20 2/15/202232,900 shares $177,660.00 -39.1%0.4%1 $5.40 1/31/202254,000 shares $260,820.00 -27.8%0.6%1.6 $4.83 1/15/202274,800 shares $377,740.00 -21.8%0.7%2.2 $5.05 12/31/202195,700 shares $430,650.00 -2.5%0.9%2.4 $4.50 12/15/202198,100 shares $485,595.00 +4.0%1.0%2.3 $4.95 11/30/202194,300 shares $722,338.00 +38.3%0.9%1.6 $7.66 11/15/202168,200 shares $554,466.00 +32.2%0.7%1 $8.13 10/29/202151,600 shares $452,016.00 +11.7%0.6%0.6 $8.76 10/15/202146,200 shares $311,850.00 -50.1%0.5%0.5 $6.75 9/30/202192,500 shares $771,450.00 +2,102.4%1.0%0.7 $8.34 9/15/20214,200 shares $28,854.00 -67.4%0.1%0 $6.87 8/31/202112,900 shares $114,681.00 -16.2%0.1%0.1 $8.89 8/13/202115,400 shares $158,928.00 No Change0.2%0.1 $10.32 TCRX Short Interest - Frequently Asked Questions What is TScan Therapeutics' current short interest? Short interest is the volume of TScan Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 398,000 shares of TCRX short. 1.03% of TScan Therapeutics' shares are currently sold short. Learn More on TScan Therapeutics' current short interest. What is a good short interest ratio for TScan Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TCRX shares currently have a short interest ratio of 2.0. Learn More on TScan Therapeutics's short interest ratio. What is a good short interest percentage for TScan Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.03% of TScan Therapeutics' floating shares are currently sold short. Is TScan Therapeutics' short interest increasing or decreasing? TScan Therapeutics saw a decline in short interest during the month of April. As of April 30th, there was short interest totaling 398,000 shares, a decline of 5.2% from the previous total of 419,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is TScan Therapeutics' float size? TScan Therapeutics currently has issued a total of 52,860,000 shares. Some of TScan Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. TScan Therapeutics currently has a public float of 38,530,000 shares. How does TScan Therapeutics' short interest compare to its competitors? 1.03% of TScan Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to TScan Therapeutics: Ocugen, Inc. (18.61%), Lexeo Therapeutics, Inc. (4.34%), C4 Therapeutics, Inc. (14.74%), Replimune Group, Inc. (19.05%), Voyager Therapeutics, Inc. (7.74%), Editas Medicine, Inc. (24.93%), Fate Therapeutics, Inc. (19.45%), Taysha Gene Therapies, Inc. (9.04%), Solid Biosciences Inc. (3.01%), Aura Biosciences, Inc. (6.95%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short TScan Therapeutics stock? Short selling TCRX is an investing strategy that aims to generate trading profit from TScan Therapeutics as its price is falling. TCRX shares are trading up $0.21 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against TScan Therapeutics? A short squeeze for TScan Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TCRX, which in turn drives the price of the stock up even further. How often is TScan Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TCRX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Ocugen Short Squeeze Lexeo Therapeutics Short Squeeze C4 Therapeutics Short Squeeze Replimune Group Short Squeeze Voyager Therapeutics Short Squeeze Editas Medicine Short Squeeze Fate Therapeutics Short Squeeze Taysha Gene Therapies Short Squeeze Solid Biosciences Short Squeeze Aura Biosciences Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TCRX) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsBill Clinton Backing Biden Replacement???The Freeport SocietyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe #1 Crypto for AIWeiss Ratings